stars 1 stars 2 stars 3

IntrepiCyte is focused on licensing its unique, noninvasive, proprietary intranasal therapeutic cell delivery technology which targets stem cells, immune cells, genetically engineered cells, and other therapeutic cells to damaged or diseased areas of the central nervous system in order to treat a variety of neurological, psychiatric, and behavioral disorders.

IntrepiCyte Questions

William Frey is the CEO of IntrepiCyte.

1 people are employed at IntrepiCyte.

Top IntrepiCyte Employees

View Similar People
Learn More
How It Works
get free account
Get a Free Account
Sign up for a free account. No credit card required. Up to 5 free lookups.
search page
Search the #1 Contact Database
Get contact details of over 700M profiles across 60M companies – all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
get contact page
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users